A German drug firm is preparing itself to market a pill for pre-menopausal women who are upset with low sexual desire, and is also ready to fight for Food and Drug Administration consent at a trial on Friday.

Pharmaceutical firms have been on a never-ending mission for a female drug that is equivalent to Viagra, which had been launched in the year 1998, and many are of the belief that flibanserin holds promise for women who consider that they have been left behind.

Boehringer Ingelheim came upon the potential of flibanserin when it was examined as an antidepressant and succumbed with some desirable aftereffects, such as it made sex more pleasurable for women and appeared to have increased their libido.

If the FDA's board of specialists gives their approval to flibanserin Friday, the drug corporation gets some edging benefits too, like an expected $2 billion in profits, equal or greater than yearly sales of the three top men's sex drugs, Viagra, Levitra and Cialis.

Boehringer has already started online advertisements with celebrity spokesperson, Lisa Rinna, an ex- Playboy model and soap opera actress, who says she too suffers from female sexual dysfunction and is happy being part of the promotional activities.